Investors
Leadership
Role and responsibilities of the Board and its principal committees
The Board is responsible to shareholders for good corporate governance, setting the Group’s strategic objectives, values and standards, and ensuring the necessary resources are in place to achieve the objectives.
At 31 December 2024, the Board comprised eight members, comprising the Chair, five independent Non-Executive Directors and two Executive Directors. Our Chair, and Chair of the Nomination Committee is Daniel Dayan. The Senior Independent Non-Executive Director is Patrick Larmon, who will step down from his SID role in May 2025 and will be replaced by Lili Chahbazi. Kevin Boyd is Audit Committee Chair and Cynthia Gordon is Remuneration Committee Chair. Biographical details of all Directors are set out on Our board page.
All Directors are encouraged to be open and forthright in their approach as we believe this helps to develop strong working relationships, enabling them to make their best possible contribution, with Non-Executive Directors encouraged to share their experiences, whilst providing constructive challenge.
Regular meetings between the Chair and Chief Executive Officer are held throughout the year, allowing general matters to be discussed and enabling them to reach an understanding of each other’s views. The Chair and SID also maintain regular contact between scheduled Board meetings, with time also set aside at meetings for the Chair to meet with Non-Executive Directors without the presence of management. The relationships between these roles are important, as these individuals represent the views of both management and Directors, respectively. The combination of these meetings ensures that the Chair is fully informed of all views, which assists in setting agendas and ensures all Directors can contribute effectively through their individual and collective experiences.
Related content
Contact us
See how Bodycote can help you with your Investor enquiries